SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences is trending as investors anticipate the final 80th event milestone for the REGAL Phase 3 trial, fueling high-conviction discussions regarding a potential lucrative buyout. The community remains focused on the company's significant short interest and the strategic positioning of its pipeline, which many believe could command a substantial valuation in the oncology market.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is trending as retail investors and social media communities actively debate a potential volatility squeeze amid elevated short interest, while bullish sentiment centers on defense sector collaborations with companies like Palantir and Lockheed Martin. The stock is currently experiencing heavy volume and high volatility, with traders closely watching whether ongoing price compression will resolve into a major directional breakout or continued downside pressure.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood ($HOOD) is trending as investors react to a flurry of product announcements from its 'World Is Flat' event, including international expansion, crypto infrastructure upgrades, and agentic AI integration. The stock is also gaining momentum from heightened retail engagement surrounding government-backed 'Trump Accounts' for children, fueling community speculation about long-term platform growth and market leadership.

Spdr Dow Jones Industrial Average ETF Trust - Spdr Dow Jones Industrial Average ETF Trust

Market sentiment remains divided as investors weigh ongoing geopolitical tensions in the Strait of Hormuz against continued rotation out of mega-cap technology into industrial and defensive sectors. Community discussion is heavily focused on whether current all-time highs in the Dow represent structural market resilience or a speculative bubble driven by artificial liquidity and unsustainable AI-related spending.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

Marathon Digital Holdings is currently a focal point for investors debating its transition from a pure-play Bitcoin miner to a diversified AI and data center infrastructure company. Community sentiment remains highly polarized, with active discussions weighing the potential of long-term strategic pivots against frustration over persistent management turnover, dilution concerns, and high-beta price volatility.

Investment Managers Series Trust II - Tradr 2X Long SNDK Daily ETF

Tradr 2X Long SNDK Daily ETF

SNXX is seeing heavy trading activity as investors leverage the momentum of the semiconductor sector, specifically mirroring the volatility and recent price swings in underlying memory-chip stocks. Community discussions remain polarized, with some traders actively using the 2x leveraged product for aggressive short-term scaling while others express concerns over decay risks and the potential for rapid unwinding.

Hut 8 Corp. engages in the development and operation of data centers at scale, supporting AI, high-performance computing (HPC), ASIC compute, and other energy-intensive technology applications. It operates through the following segments: Power, Digital Infrastructure, Compute, and Others. The Power segment manages the origination, development, and management of powered land and energy infrastructure. The Digital Infrastructure refers to the development, ownership, and operation of facilities designed to support next-generation, energy-intensive technology application. The Compute segment deals with operating businesses that deploy and monetize compute assets across next-generation energy-intensive technology. The Others segment offers equipment sales and repairs. The company was founded on January 27, 2023 and is headquartered in Miami, FL.

Hut 8 Corp

Hut 8 Corp is trending as investors aggressively re-rate the former Bitcoin miner into an AI infrastructure play, fueled by major data center contract wins and significant institutional interest. The community is actively debating the stock's transition to a pure-play data center operator, with ongoing discussions centered on high-upside analyst price targets and whether the stock's rapid appreciation has outpaced its current technical support.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is facing significant selling pressure amid broader cooling in the AI infrastructure sector, compounded by investor backlash over substantial executive compensation packages and persistent dilution concerns. Despite the negative sentiment and recent price volatility, the community remains divided, with some investors focusing on the company's long-term potential in the gigawatt-scale data center market while others are frustrated by management's strategic communication and the lack of immediate contract catalysts.

Direxion Shares ETF Trust - Direxion Daily MSCI South Korea Bull 3X ETF

Direxion Daily South Korea Bull 3X Shares

KORU is experiencing extreme volatility as investors rotate out of heavily leveraged semiconductor positions amid broader market cooling and technical rebalancing concerns. The community remains deeply divided, with many traders actively debating whether the aggressive sell-off provides a long-term discount entry point or signals the beginning of a larger structural decline for leveraged tech-focused ETFs.

Lemonade, Inc. is a holding company, which engages in the provision of insurance services. The firm's products include renters and homeowners insurance, and pet insurance. It offers insurance coverage under the homeowners multi-peril, inland marine, and general liability lines of business. The company was founded by Daniel Asher Schreiber and Shai Wininger on June 17, 2015 and is headquartered in New York, NY.

Lemonade Inc

Lemonade is seeing significant market interest as traders weigh its AI-driven underwriting model against broader volatility in the fintech and insurtech sectors. The community remains focused on whether the company's growth trajectory and recent technical breakouts can sustain momentum through upcoming earnings, with active discussions centering on the potential for institutional accumulation and the long-term viability of its automated insurance platform.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Silence Therapeutics plc (SLN) Initiated at Overweight as Analyst Highlights siRNA Pipeline Potential

Silence Therapeutics plc (SLN) Initiated at Overweight as Analyst Highlights siRNA Pipeline Potential...

Silence Therapeutics (SLN) Surges 26.0%: Is This an Indication of Further Gains?

Silence Therapeutics (SLN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

This $300 Million Biotech May Be Deeply Mispriced: Analyst

Silence Therapeutics ($SLN) stock surges as Cantor predicts key August Phase 2 data will be a major catalyst in the PV market.read more...

Silence Therapeutics Highlights Follow-Up Data at EHA 2026 Demonstrating Durable Efficacy and Potential Best-in-Class Profile for Divesiran in Polycythemia Vera

Silence Therapeutics plc (Nasdaq: SLN), a global clinical-stage biotechnology company developing novel siRNA (short interfering RNA) therapies, today presented follow-up and quality-of-life data from the Phase 1 SANRECO study evaluating divesiran, a first-in-class siRNA therapy targeting TMPRSS6...

Silence Therapeutics to Participate in Jefferies Global Healthcare Conference

Silence Therapeutics plc (Nasdaq: SLN), a global clinical-stage biotechnology company developing novel siRNA (short interfering RNA) therapies, today announced that management will participate in an analyst-led fireside chat at the Jefferies Global Healthcare Conference on Wednesday, June 3, 2026...

Silence Therapeutics to Participate in H.C. Wainwright BioConnect Investor Conference

Silence Therapeutics plc (Nasdaq: SLN), a global clinical-stage company developing novel siRNA (short interfering RNA) therapies, today announced that Curtis Rambaran, MD, Chief Medical Officer of Silence Therapeutics, will participate in a fireside chat at the H.C. Wainwright BioConnect Investor...

Silence Therapeutics Highlights Recent Business Achievements and Reports First Quarter 2026 Financial Results

Silence Therapeutics plc, Nasdaq: SLN (Silence or the Company), a global clinical-stage company developing novel siRNA (short interfering RNA) therapies, today reported its financial results for the...

Silence Therapeutics PLC Sponsored ADR (NASDAQ:SLN) Short Interest Up 13.3% in April

Silence Therapeutics PLC Sponsored ADR (NASDAQ:SLN - Get Free Report) was the recipient of a large increase in short interest in April. As of April 15th, there was short interest totaling 2,075,273...

Silence Therapeutics PLC Sponsored ADR (NASDAQ:SLN) Given Average Rating of "Moderate Buy" by Brokerages

Silence Therapeutics PLC Sponsored ADR (NASDAQ:SLN - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the seven ratings firms that are presently covering the stock...

Silence Therapeutics (NASDAQ:SLN)  Shares Down 1.8%   - Here's What Happened

Silence Therapeutics (NASDAQ:SLN) Trading Down 1.8% - Here's Why...

Silence Therapeutics Plc engages in the discovery, delivery, and development of ribonucleic acid (RNA) therapeutics. It also develops medicines by harnessing the body's natural mechanism of RNA interference within its cells. The company was founded on November 18, 1994 and is headquartered in London, the United Kingdom.

Silence Therapeutics Plc - ADR

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$10.39
Prev Close	$10.50
Open	$10.66
Dividend Yield	0.00%
50-Day Moving Average	$7.33
Beta	0.90
Avg. Volume	504,621.03
PE Ratio	-6.53

52-Week High	$11.06
52-Week Low	$4.19
Market Capitalization	$490.77M
EPS (Annual)	-$1.88
Price to Book	9.93
Revenue Per Employee	$6,367.11

Feed

News

Sentiment

Earnings

Fundamentals

Info

SLNSilence Therapeutics Plc - ADR

Latest SLN News